Back to the main directory
EarningsReview / Equity
- Re-joining the salmon run by BNP Paribas Exane
- HusCompagniet - Focus is now on markets, not margins by Danske Bank Equity Research
- US bank failures - the ripple effects by BNP Paribas Exane
- Sustainability Weekly 6 – 10 March 2023 by Oddo BHF
- Phoenix Group (PHNX LN) by HSBC
- EQUITA SIM: REVO BUY (Unchanged) - FY22 results by Equita Sim
- Nedbank (NED SJ) by HSBC
- NIO Inc (NIO US) by HSBC
- Prices, volumes, arbitrage opportunities, and implications on company profits by BNP Paribas Exane
- Hosted Investor Meetings; Gravity of the Situation by BNP Paribas Exane
- JinkoSolar Holding (JKS US) by HSBC
- Will FCF 2023 turn positive amid improving EBITDA? by BNP Paribas Exane
- Solid trends continue by BNP Paribas Exane
- Strong Pulp execution, but fading order momentum by BNP Paribas Exane
- In the Flow by BNP Paribas Exane
- Q4: under stress, though management sees light ahead by BNP Paribas Exane
- Arjo (Buy, TP: SEK60.00) - Q1 likely 2023’s weakest quarter by DnB Markets
- Itaú BBA on Concha y Toro: Wine Volumes Down 14% YoY in 4Q22 by Itau
- Sherlock Homes II: Should we be more bearish on US resi? by BNP Paribas Exane
- Watson-Marlow: A 2024, not a H2''23 recovery story? by BNP Paribas Exane
- Investment Daily 14/03/2023 by BNP Paribas Exane
- Oryzon Genomics - New clinical candidate expands CNS portfolio by Edison Investment Research
- INVEST SECURITIES - ICADE : Cession de 100% d'Icade Santé, positive boursièrement à court terme mais discutable à moyen terme - ACHAT, OC 57,2€) by Invest Securities
- 中国自动化行业 by HSBC
- 百济神州（BGNE US） by HSBC